Jason Jones Net Worth

The estimated Net Worth of Jason C Jones is at least $510 millier dollars as of 8 May 2023. Jason Jones owns over 3,435 units of Ekso Bionics Inc stock worth over $156,760 and over the last 5 years he sold EKSO stock worth over $41,521. In addition, he makes $312,157 as Vice-President of Product Development at Ekso Bionics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jason Jones EKSO stock SEC Form 4 insiders trading

Jason has made over 5 trades of the Ekso Bionics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,435 units of EKSO stock worth $5,393 on 8 May 2023.

The largest trade he's ever made was selling 9,430 units of Ekso Bionics Inc stock on 31 May 2019 worth over $12,353. On average, Jason trades about 1,628 units every 103 days since 2019. As of 8 May 2023 he still owns at least 138,554 units of Ekso Bionics Inc stock.

You can see the complete history of Jason Jones stock trades at the bottom of the page.

Jason Jones biography

Jason Jones is the Vice-President of Product Development at Ekso Bionics Inc.

What is the salary of Jason Jones?

As the Vice-President of Product Development of Ekso Bionics Inc, the total compensation of Jason Jones at Ekso Bionics Inc is $312,157. There are 5 executives at Ekso Bionics Inc getting paid more, with Jack Peurach having the highest compensation of $660,604.

What's Jason Jones's mailing address?

Jason's mailing address filed with the SEC is 101 GLACIER POINT, SUITE A, SAN RAFAEL, CA, 94901.

Insiders trading at Ekso Bionics Inc

Over the last 9 years, insiders at Ekso Bionics Inc have traded over $898,173 worth of Ekso Bionics Inc stock and bought 276,997 units worth $399,153 . The most active insiders traders include Theodore T Wang, Steven Sherman et Russ Angold. On average, Ekso Bionics Inc executives and independent directors trade stock every 56 days with the average trade being worth of $25,243. The most recent stock trade was executed by Scott G. Davis on 17 August 2023, trading 37,446 units of EKSO stock currently worth $37,446.

What does Ekso Bionics Inc do?

since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774

Complete history of Jason Jones stock trades at Ekso Bionics Inc

Ekso Bionics Inc executives and stock owners

Ekso Bionics Inc executives and other stock owners filed with the SEC include:

• Jack Peurach,
  President, Chief Executive Officer, Director
• William R. Shaw,
  Chief Commercial Officer
• John Glenn,
  Chief Financial Officer
• Jack Peurach,
  Pres, CEO & Director
• John F. Glenn,
  CFO & Sec.
• Jason Jones,
  Vice-President of Product Development
• Steven A. Sherman,
  Exec. Chairman
• Steven Sherman,
  Executive Chairman of the Board
• David Carey,
  IR Contact Officer
• William Shaw,
  Chief Commercial Officer
• Stanley Stern,
  Independent Director
• Marilyn Hamilton,
  Independent Director
• Theodore Wang,
  Director
• Thomas Schreck,
  Independent Director
• Charles Li,
  Independent Director
• Jerome Wong,
  Corp. Controller
• Foon Lim Chwee,
  Pres of APAC
• Anthony Pratt,
  US Director of Sales
• Rachael Anderson,
  Global Director of Marketing & Strategic Growth
• Scott G. Davis,
  President & COO
• Theodore T Puissance Cross ...,
  
• Russ Angold,
  President, Ekso Labs
• Tom Looby,
  President & Chief Com. Officer
• Kecheng Li,
  Director
• Russ De Lonzor,
  Vice Pres., Operations
• Max Scheder Bieschin,
  Chief Financial Officer
• Gregory Davault,
  Vice Pres., Global Marketing
• Daniel Boren,
  Director
• Amy Mc Bride Wendell,
  Director
• Howard D Palefsky,
  Director
• Nathan Harding,
  Chief Executive Officer
• Rhonda A. Wallen,
  Director
• Mary Ann Cloyd,
  Director
• Corinna Lathan,
  Director
• Deborah Lafer Scher,
  Director
• Jerome Wong,
  Chief Financial Officer